Journal
ORGANIC LETTERS
Volume 23, Issue 19, Pages 7462-7466Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.1c02673
Keywords
-
Categories
Funding
- State Key Program of National Natural Science Foundation of China [21937006]
- National Science Fund for Distinguished Young Scholars [31525005]
- National Natural Science Foundation of China [31770390, 31770340]
- Yunnan Key Research and Development Program [2019ZF011-2]
- Yunnan Innovative Research Team for Discovery and Biosynthesis of Bioactive Natural Products [2018HC012]
- Natural Science Foundation of Yunnan [2018FA017]
- Youth Innovation Promotion Association
- Western Light Program of CAS
Ask authors/readers for more resources
Two novel triterpenoid saponins, colqueleganoids A and B, were isolated from the root of Colquhounia elegans, featuring a unique carbon skeleton colquelegane with methyl-30. These compounds were found to significantly enhance TNF-alpha production and IL-6 production in RAW264.7 macrophages stimulated with lipopolysaccharide, suggesting their potential as immunostimulants for immunotherapy and vaccination.
Two novel triterpenoid saponins, colqueleganoids A (1) and B (2), with the first methyl-30 incorporated 6/6/6/6-cyclized carbon skeleton (named colquelegane), were isolated from the root of Colquhounia elegans. Their structures including absolute configuration were determined by spectroscopic methods and X-ray crystallographic analyses. Interestingly, both compounds significantly enhanced TNF-alpha production and 1 also increased the IL-6 production in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS), suggesting their potential application as immunostimulants in immunotherapy and vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available